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1. Introduction 
Studies of the specific binding of glycoprotein 
hormones to their receptors require labelled com- 
pounds of high specific radioactivity. The most 
frequent procedure for labelling glycoprotein hor- 
mones is iodination, but incorporation of tritium into 
t.he glycoprotein molecule by modification of the 
sialic acid residues has also been employed for this 
purpose [1,2]. We reported recently [3,4] that 
reductive methylation of ovine luteinizing hormone, 
using the procedure of Means and Feeney [5], could 
be achieved without loss of biological activity. We 
now report a procedure for the tritiation of LH* by 
reductive methylation of its lysine residues with tri- 
tiated NaBH4. The tritiated LH derivative fully 
retains its biological potency when measured by the 
ovarian ascorbic acid depletion bioassay of Parlow 
[6]. Our experiments show this derivative to be of 
advantage for the study of the binding of this 
hormone to its receptors ]7,8]. 
2. Experimental 
2.1. Materials 
Ovine luteinizing hormone, prepared as described 
elsewhere [9], was a generous gift of Dr Jutisz; its 
potency (Batch P73bd) was approximately 2.70 X 
NIH-LH-Sl 1 (confidence limits for P of 0.05 = 1.81- 
* LH will be used as an abbreviation of luteinizing hormone. 
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4.14) as assayed by tne rarlow test. Tritiated NaBH4 
(S-20 Cilmmole) was purchased from NEN Chemicals 
ana mogel P- 100, used for purification, was supplied 
by Bio Rad. All other chemicals and solvents were of 
analytical grade from Prolabo or Merck. Amino-acid 
analyses were performed in a 22-hr Technicon Auto- 
-analyzer;. a special gradient, containing propanol, was 
used to separate lysine, dimethylated lysine and 
monomethylated lysine [5]. Tritium determinations 
were made with a Packard Tri-Carb liquid scintillation 
counter. Absorbance was measured with a Beckman 
Spectrophotometer Acta C II. 3 H compounds were 
stored in liquid nitrogen. Biological potency was 
assayed by the ovarian ascorbic acid depletion bio- 
assay [6]. The solutions assayed were prepared in 
polyallomer tubes (Beckman centrifuger tubes) 
because adsorption of methylated LH on this material 
is negligible [4]. 
2.2. Preparation of tritiated methylated luteinizing 
hormone 
The methylation reaction was accomplished at 
4°C. 0.6 mg of tritiated NaBH4 (dissolved in 0.5 ml 
of a borate buffer pH 9, 0.2 M) was added to 4 mg 
of ovine LH dissolved in 0.5 ml of the same buffer. 
Ten ~1 of 10 M formaldehyde were then slowly intro- 
duced by repetitive additions, as recommended by 
Means and Feeney [5]. 
After maintaining the reaction mixture at 4°C for 
1 hr, 1 ml of pyridinium acetate (pH 5, 2.5 M) was 
added to decompose the unreacted borohydride. 
Labile hydrogens were then removed by successive 
flash evaporation with distilled water. The volume 
was finally reduced to 1 ml. 
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Fig. 1. Gel filtration of tritiated methylated luteinizing hormone on a Biogel P-100 column. Arrows indicate the elution 
volumes corresponding to the void volume (Vo), native luteinizing hormone (LH) and LH subunits (SU). 
2.3. Purification 
The tritiated material was then filtered on a Biogel 
P 100 column (0.9 X 125 cm) in order to obtain its 
purification. The column was eluted by pyridinium 
acetate 0.05 M pH 5 at 4°C. Fig. 1 shows a typical 
elution pattern. (Elution patterns obtained using 
absorbance measurements or tritium counting are 
superposable.) The same pattern was observed with 
all the active preparations: only one symmetrical 
peak is obtained at the elution volume corresponding 
to that of undissociated LH. Dissociated subunits or 
denatured material (eluted in the void volume) appear 
only when the specified conditions of methylation 
were not respected (for instance, the temperature). 
They are clearly separated from the native dimer 
by this method, as has been established in the prep 
aration of other LH derivatives [lo]. The elution 
peak corresponding to the pure tritiated hormone 
was then lyophilized and its weight determined. The 
yield was 78%. Labelled methylated luteinizing 
hormone tias redissolved in a phosphate buffer 0.1 M, 
pH 7.4 (0.2 mg/ml) solution. This solution was 
stored in. liquid nitrogen. 
2.4. Degree of methylation 
As reported [4], small differences in the degree 
of alkylation are observed after reductive methylation 
of luteinizing hormone, depending on the conditions 
of the reaction. 
Table 1 shows the degree of alkylation of two 
preparations of tritiated methylated LH. Under the 
conditions described above, the methylation of 75% 
Table 1 
Degree of alkylation and specific radioactivity of tritiated methylated luteinizing hormone 
Methylated derivative Dimethyl Lys Monomethyl Lys Free Lys Ci/mmole 
Preparation 72 60 10 30 98 
Preparation 73t 84 6 10 35 
t The specific radioactivity of the tritiated NaBH4 used in this experiment was 6.51 Ci/mmole. 
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Table 2 
Biological activity of tritiated methylated luteinizing hormone (LH) 
Relative potencies in 
Relative potencies in 
Period of storage at -196°C terms of native LH terms of unlabelled 
methylated LHt 
First month 
8th month 
1.69 (0.83-3.4) 
2.07 (0.88-4.8) 1.12 (0.54-2.3) 
1.00 (0.55-1.82) 0.62 (0.34-1.10) 
Relative potencies and 95% confidence limits are expressed in terms of either native 
luteinizing hormone or methylated luteinizing hormone. 
t The relative potency of this preparation with respect o native LH was measured in 
three separate bioassays: March 1972: 1.43 (1.01-2.02); May 1973: 1.76 (0.65-4.8): 
March 1974: 1.52 (0.68-3.46). 
of the lysine residues is easily achieved, but 90% of 
alkylation is unusual. 
2.5. Specific radioactivity 
The specific radioactivities obtained with two 
distinct preparations are indicated in table 1. These 
were determined by counting tritium radioactivity 
of samples whose mass was established by weight 
measurements as well as by absorbance measurement. 
The differences between the values shown in table 1 
are due to the different specific radioactivities of the 
tritiated borohydride used. 
2.6. Biological activity 
The biological potency of the labelled hormone 
was measured by the ovarian ascorbic acid depletion 
bioassay during the first month after its preparation 
and 8 months later. Table 2 shows the relative 
potencies observed, using as standard, either unlabel- 
led native LH or methylated non-tritiated LH con- 
taining 75% of modified lysine residues. As can be 
seen, no significant differences exist between the 
biological potency of freshly prepared [“HI methyl- 
ated LH and unlabelled methylated LH, but the 
relative potency of labelled methylated LH is about 
twice that of the native LH. Differences in the degree 
of methylation seem to have little influence, if any, 
on the biological activity. The labelled methylated LH 
reported in table 2 contains 90% of its lysine residues 
modified. Similar results were obtained previously 
with the unlabelled methylated LH [4]. However, 
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after 8 months of storage in liquid nitrogen, the 
relative potency of [3H]methylated LH would 
appear to decrease to about half of the original 
activity. This would suggest some radiolysis. 
3. Discussion 
As would be expected, methylation of luteinizing 
hormone with tritiated borohydride can be achieved 
with similar results to those observed when unlabelled 
NaBH4 was used [4]. 
It is interesting to compare the specific radio- 
activity obtained with that expected from theoretical 
considerations. Reductive methylation is achieved 
probably by the addition of two atoms of hydrogen 
to the double bond of a Schiff base, one of these 
hydrogen atoms being exchangeable. As the a-amino 
group of the a-subunit of LH was probably methylated 
to the same extent as the e-NH2, it appears (table 1, 
preparation 73) that our results agree with the 
theoretical value. It may be concluded that, as claimed 
by Means and Feeney [S], reductive methylation is a 
specific reaction which affects only free amino groups. 
On the other hand, the amino groups of glucosamine 
and galactosamine do not seem to react. This would 
suggest hat, as firstly proposed by Ward and Coffey 
[ 111, they are blocked (acetylated). 
The potency of methylated derivatives is greater 
than that of native LH in the ovarian ascorbic acid 
depletion test. However, preliminary work in our 
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laboratory (C. Hermier, M. Evrard, P. Lebouleux, 
P. De La Rosa, unpublished results) indicates that the 
differences in potency between methylated and native 
LH, observed in the Parlow test, could be due to 
differences in clearance rates. When ovaries from 
pseudopregnant rats are incubated in vitro for 3 hours 
in the presence of LH or its derivatives [ 121, no 
significant difference is found in the stimulatory 
potencies of native LH, unlabelled methylated LH and 
labelled methylated LH. 
Methylated LH derivatives offer several advantages 
over the iodinated LH, (i) the degree of methylatiofi 
and the corresponding variation in biological activity 
can be controlled more easily than in the case of 
iodination [13], (ii) the specific radioactivity and the 
biological potency are stable for several months, (iii) 
reductive alkylation is a very gentle reaction which 
allows incorporation of a considerable number of 
tritium atoms in the LH molecule without danger of 
secondary reactions. Other methods proposed fat the 
incorporation of tritium into the gonadotropin 
molecules involve more drastic reactions, such as 
oxidation of sugar residues [ 1,2]. Moreover, this last 
reaction precludes the introduction of a large number 
of tritium atoms in the molecule. Reductive methyla- 
tion using [’ ’ C] formaldehyde can also be employed 
to incorporate atoms of I1 C into the LH molecule, as 
will be published elsewhere. The only limitation to 
the generalization of this procedure for labelling 
hormones arises from the fact that the alteration 
introduced in the -NH2, even though small, may 
have, in some cases, a considerable effect on biologicai 
activity. 
Tritiated methylated LH has been used in our 
laboratory for the investigation of the binding of LH 
to bovine corpora lutea. The K, found, using either 
the homogenate pellet or purified plasma membranes 
incubated with this derivative, are in good agreement 
with the results found by other authors [7,14,15]. 
Furthermore, by using the [3 H] methylated LH, 
evidence was obtained for the binding of ovine LH 
to a soluble macromolecular constituent within the 
bovine corpus luteum cytosol fraction [8]. 
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